Management of Cepacia syndrome in an immunocompetent non-cystic fibrosis adult patient.
Int J Infect Dis
; 122: 550-552, 2022 Sep.
Article
in English
| MEDLINE | ID: covidwho-1966624
ABSTRACT
Burkholderia cepacia complex (BCC) is nonfermenting, Gram-negative bacteria known to cause high morbidity and mortality. They commonly affect patients with cystic fibrosis (CF) and are often missed in those without, despite being fatal if left untreated. We report a case of cepacia syndrome in a 42-year-old, immunocompetent man without CF who initially presented with sepsis secondary to pneumonia. Multiple isolates from blood, synovial fluid, and wound swabs grew BCC. Treatment options and management strategies remain poorly understood for BCC in general and in cases without CF in specific. We successfully treated the patient using a combination of intravenous and inhalational antibiotics. This case report elaborates on the disease presentation, investigations, and management strategy employed to treat this rare infection.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Burkholderia Infections
/
Cystic Fibrosis
/
Burkholderia cepacia complex
Type of study:
Case report
/
Diagnostic study
Topics:
Long Covid
Limits:
Adult
/
Humans
/
Male
Language:
English
Journal:
Int J Infect Dis
Journal subject:
Communicable Diseases
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS